Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Active, not recruiting · NCT02262832 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, lipodystrophy, metabolic disease, skin disorder | Active, not recruiting | Phase 3 | 2026-09-22 | NCT02262832 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |